NALLPEN Drug Patent Profile
✉ Email this page to a colleague
When do Nallpen patents expire, and what generic alternatives are available?
Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.
The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nallpen
A generic version of NALLPEN was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
Summary for NALLPEN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 5,541 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NALLPEN at DailyMed |